Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Shrinking Industry Group Rank Makes Medtronic (MDT) a Sell

By Portfolio Grader
Medtronic Plc (NYSE:MDT) is ranked as a Sell using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MDT has had from Portfolio Grader for 4 months.

Royal Bank of Canada (RY) a Buy on Solid Quant Score

By Portfolio Grader
Royal Bank of Canada (NYSE:RY) ranks in the top decile in its industry group, Banks, and in the top decile of sector group, Financials, with a market value of $117.0 billion. From an investment attractiveness vantage point, RY is ranked in the top quartile of the sector with a ranking of 147 among the 770 companies in the sector; the stock's Portfolio Grader ranking places it 65 among the 346 companies in this industry group, putting in the top quartile and number 725 in the 5000 company Portfolio Grader company universe.

Should You Buy Netflix, Inc. Stock? 3 Pros, 3 Cons

By Lucas Hahn, InvestorPlace Contributor
NFLX earnings have shown impressive growth, and Netflix stock has grown in both volume and pricing, but the stock is not without risks.

Citigroup’s (C) Superior Earnings Visibility Makes it a Buy

By Portfolio Grader
The current recommendation of Buy for Citigroup Inc (NYSE:C) is derived using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. C has maintained this ranking for 2 months.

HSBC Holdings plc Sponsored ADR (HSBC) a Buy on Strong Quant Score

By Portfolio Grader
As one of the 770 companies in the GICS Financials sector HSBC Holdings plc Sponsored ADR (NYSE:HSBC) is a constituent of the 346 company Banks GICS industry group within this sector. HSBC has a market value of $201.9 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for HSBC puts it 86 among the 346 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 188 among the 770 companies in the sector, and number 970 in the nearly 5,000 company Portfolio Grader universe.

Sales Growth Makes Wells Fargo & Co (WFC) a Sell

By Portfolio Grader
Wells Fargo & Co (NYSE:WFC) is one of the 770 companies in the GICS Financials sector, and a component of the 346 company Banks GICS industry group within this sector. WFC's market value is $270.6 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 288 among the 346 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 617 among the 770 companies in the sector, and number 3,214 in the nearly 5,000 company Portfolio Grader universe.

Strong Earnings Growth Keeps Bank of America (BAC) a Buy

By Portfolio Grader
With a $284.1 billion market value, Bank of America Corp (NYSE:BAC) ranks in the top decile in its industry group, Banks, and in the top 10% of its sector group, Financials, in market value. From the prospective of investment attractiveness, the ranking for BAC by Portfolio Grader places it 143 among the 346 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 301 among the 770 companies in the sector, and number 1,557 in the nearly 5,000 company Portfolio Grader universe.

JPMorgan Chase & Co (JPM) a Buy on Robust Quant Score

By Portfolio Grader
With a $345.3 billion market value, JPMorgan Chase & Co (NYSE:JPM) ranks in the top 10% of its industry group, Banks, and in the top decile of sector group, Financials, in market value. From the vantage point of investment attractiveness, Portfolio Grader's current ranking for JPM puts it 94 among the 346 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 205 among the 770 companies in the sector, and number 1,051 in the nearly 5,000 company Portfolio Grader universe.

Berkshire Hathaway Energy (BRK.B) a Hold on Weak Earnings Growth

By Portfolio Grader
Currently, Berkshire Hathaway Energy Co (NYSE:BRK.B) has a Hold using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. BRK.B has maintained this ranking for 4 months.

A Growth Slowdown Is Coming for Sirius XM Holdings Inc. Stock

By Vince Martin, InvestorPlace Contributor
Sirius XM trades near all-time highs, but challenges ahead make Sirius XM stock a dicey proposition at current levels.

Banco Santander Brasil (BSBR) a Buy on Superior Earnings Visibility

By Portfolio Grader
Banco Santander Brasil SA (NYSE:BSBR) is a constituent of the 346 company Banks GICS industry group, which is part of the 770 company GICS Financials sector. BSBR has a market value of $36,144.4 billion which is in the top decile in its industry group. The ranking for BSBR by Portfolio Grader places it 147 among the 346 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 310 among the 770 companies in the sector, and number 1,633 in the nearly 5,000 company Portfolio Grader universe.

Facebook Inc (FB) Stock Is Not Low Enough for a Buy In or Cash Out

By Bret Kenwell, InvestorPlace Contributor
Facebook has been on fire, up more than 50% so far in 2017. Despite this, FB stock price today is not as overvalued as you might think.

3 Reasons Alphabet Inc (GOOGL) Needed to Buy into Lyft’s Future

By James Brumley, InvestorPlace Feature Writer
The GOOGL stock price didn't budge on the news, and rightfully so. But, the Lyft funding from Alphabet speaks volumes about where Waymo may be.

Vertex Pharmaceuticals (VRTX) a Buy on Solid Earnings Momentum

By Portfolio Grader
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is classified as a member of the 345 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. VRTX has a market value of $38.8 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for VRTX puts it 40 among the 345 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 133 among the 782 companies in the sector, and number 983 in the nearly 5,000 company Portfolio Grader universe.

Cellect Biotechnology’s (APOP) Strong Quant Score Makes it a Buy

By Portfolio Grader
Cellect Biotechnology Ltd (NULL:APOP) is one of 345 companies within the Biotechnology GICS industry group, which is in turn part of the 782 company GICS Health Care sector. APOP has a market value of $42.6 billion which is in the top decile in its industry group. The stock's current Portfolio Grader score places it 21 among the 345 companies in this industry group, putting it in the top decile; in the top quartile of the sector with a ranking of 93 among the 782 companies in the sector, and number 687 in the nearly 5,000 company Portfolio Grader universe.

10 Top Trending Halloween Costumes for 2017

By Karl Utermohlen, InvestorPlace Writer
We have compiled the 10 top trending Halloween costumes for 2017, only a week before the spooky holiday. Superheroes are still very popular.

Shire (SHPG) a Sell on Falling Quant Score

By Portfolio Grader
Portfolio Grader currently ranks Shire plc (NASDAQ:SHPG) a Sell. The system for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking SHPG has had from Portfolio Grader for 11 months.

5 Stocks That Are Going Vertical

By Anthony Mirhaydari, InvestorPlace Market Strategist
U.S. equities are hitting new highs, and as a result a number of stocks are taking on a moon-shot trajectory.

Earnings Visibility Keeps MLP & Strategic Equity Fund (MTP) a Sell

By Portfolio Grader
MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 345 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. MTP's market value is $44.1 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 303 among the 345 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 693 among the 782 companies in the sector, and number 4,218 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles